New study aims to personalize care for rare blood disorders
NCT ID NCT07206095
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with sickle cell disease or other rare anemias. Researchers want to use advanced genetic and blood tests to better understand each person's condition. The goal is to make diagnosis more precise so that treatments can be tailored to each patient. About 200 participants will join this research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA DUE TO MEMBRANE DEFECT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Consorci Sanitari de Terrassa
RECRUITINGTerrassa, Barcelona, 08227, Spain
-
Consorci Sanitari del Maresme - Hospital de Mataró
RECRUITINGMataró, Barcelona, 08304, Spain
-
Hospital General de Granollers
RECRUITINGGranollers, Barcelona, 08402, Spain
-
Hospital Sant Joan de Déu
RECRUITINGEsplugues de Llobregat, Barcelona, 08950, Spain
-
Hospital Universitari Arnau de Vilanova
RECRUITINGLleida, Lleida, 25198, Spain
-
Hospital Universitari Mútua de Terrassa
RECRUITINGTerrassa, Barcelona, 08221, Spain
-
Hospital Universitari Vall d'Hebron
RECRUITINGBarcelona, Barcelona, 08035, Spain
-
Hospital de la Santa Creu i Sant Pau
RECRUITINGBarcelona, Barcelona, 08025, Spain
-
Parc Taulí Hospital Universitari
RECRUITINGSabadell, Barcelona, 08208, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Co-Designed support help parents embrace sickle cell care?
- Can community hospitals in zambia master severe disease care?
- A Pocket-Sized coach for sickle cell: can an app turn Pill-Taking into a habit?
- Can a phone app keep teens on track with sickle cell treatment?
- A common amino acid may calm sickle cell pain crises — a trial puts it to the test
- A drug that protects the liver may make stem cell transplants safer for children with sickle cell disease